Elevance Health (ELV) Notes Payables (2009 - 2026)

Elevance Health (ELV) has reported Notes Payables for 18 consecutive years, with $724.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Notes Payables rose 189.6% year-over-year to $724.0 million in Q1 2026; TTM through Mar 2026 was $724.0 million, a 189.6% increase from a year earlier, with the FY2025 full-year figure at $150.0 million, down 58.9% from the prior year.
• Notes Payables was $724.0 million for Q1 2026 at Elevance Health, up from $150.0 million in the prior quarter.
• Over five years, Notes Payables peaked at $1.6 billion in Q1 2024 and troughed at $150.0 million in Q4 2025.
• A 5-year average of $370.2 million and a median of $265.0 million in 2022 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables soared 494.34% in 2024 and sank 84.13% in 2025, its largest moves.
• Over 5 years, Notes Payables stood at $265.0 million in 2022, then decreased by 15.09% to $225.0 million in 2023, then soared by 62.22% to $365.0 million in 2024, then tumbled by 58.9% to $150.0 million in 2025, then jumped by 382.67% to $724.0 million in 2026.
• The last three Notes Payables figures came in at $724.0 million (Q1 2026), $150.0 million (Q4 2025), and $180.0 million (Q3 2025), per Business Quant data.